Observational Study to Assess Transradial Access for Treatment in the Lower Extremities.
NCT ID: NCT04371861
Last Updated: 2023-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2020-06-29
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions
NCT01609621
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion
NCT00407940
Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia
NCT06277362
EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study
NCT00718991
Efficacy of Subintimal vs Intraluminal Approach for Atherosclerotic Chronic Occlusive Femoropopliteal Arterial Disease
NCT02544555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment of lower extremity lesion via transradial access.
Interventions performed are standard of care for treatment of a peripheral lesion.
Peripheral Artery Treatment
Peripheral lesions may be treated by any standard of care methods of treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peripheral Artery Treatment
Peripheral lesions may be treated by any standard of care methods of treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject scheduled for a transradial intervention to treat a lesion in the lower extremities.
* Willing to sign consent and agree to follow-up requirements.
Exclusion Criteria
* Presence of or planned dialysis fistula.
* Planned amputation
* Previous or planned transradial access intervention +/- 30 days
* Radial artery diameter \<2.5mm
* No palpable radial artery
* Established vasospastic disease
* Known allergy to contrast that cannot be managed
* Pregnant or lactating
* Mentally incompetent or a prisoner
* Currently participating in a clinical study that has not completed it's primary endpoint
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Terumo Medical Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehdi Shishehbor, DO
Role: PRINCIPAL_INVESTIGATOR
University Hospitals, Cleveland, OH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSD
La Jolla, California, United States
Northside Hospital
St. Petersburg, Florida, United States
Cardiovascular Institute of the South
Lafayette, Louisiana, United States
Mercy Hospital
Springfield, Missouri, United States
Columbia University Medical Center
New York, New York, United States
Sorin Medical, Inc.
New York, New York, United States
University Hospitals
Cleveland, Ohio, United States
Ascension Seton Hays Hospital
Kyle, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TIS2019-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.